Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes

Hepatitis A virus (HAV) is a causative agent of acute hepatitis and can occasionally induce acute liver failure. However, specific potent anti-HAV drug is not available on the market currently. Thus, we investigated several novel therapeutic drugs through a drug repositioning approach, targeting rib...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki-Tanaka, Reina, Shibata, Toshikatsu, Okamoto, Hiroaki, Moriyama, Mitsuhiko, Kanda, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910232/
https://www.ncbi.nlm.nih.gov/pubmed/35269774
http://dx.doi.org/10.3390/ijms23052631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910232/
https://www.ncbi.nlm.nih.gov/pubmed/35269774
http://dx.doi.org/10.3390/ijms23052631

Ejemplares similares